Doxorubicin and Lapatinib Combination Nanomedicine for Treating Resistant Breast Cancer

Title
Doxorubicin and Lapatinib Combination Nanomedicine for Treating Resistant Breast Cancer
Authors
Keywords
-
Journal
MOLECULAR PHARMACEUTICS
Volume 11, Issue 8, Pages 2600-2611
Publisher
American Chemical Society (ACS)
Online
2014-01-09
DOI
10.1021/mp400687w

Ask authors/readers for more resources

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now